PT Kimia Farma Tbk (IDX: KAEF) announced the results of its Extraordinary General Meeting of Shareholders (EGMS) held on November 3, 2025. In the meeting, shareholders approved two main agendas: the transfer of company assets worth more than 50% of total net assets and changes in the company’s management structure.

The meeting was attended by shareholders representing 5.002 billion shares, or 89.86% of the total outstanding shares. With this attendance, the meeting was declared valid based on the company’s Articles of Association and applicable regulations.

Rp2.16 Trillion in Assets to Be Transferred

In the first agenda, shareholders approved the transfer, handover, and write-off of 38 company assets consisting of land and buildings with a total book value of Rp2.16 trillion. The asset transfer will take place after all notes from the Board of Commissioners are resolved and once the company’s restructuring plan receives official approval.

Kimia Farma’s management explained that this step is part of a financial restructuring and asset optimization strategy. The purpose is to strengthen the company’s capital structure and increase operational efficiency. The company emphasized that the process will be carried out carefully and in line with the principles of good corporate governance (GCG) and current regulations.

New Appointments in Company Leadership

In the second agenda, shareholders approved changes in the management structure. The meeting decided to honorably dismiss Lina Sari from her position as Director of Finance and Risk Management and Wiku Adisasmito from his position as Commissioner. As replacements, shareholders appointed Willy Meridian as Director of Finance and Risk Management and Sumarjati Arjoso as Commissioner.

The new management structure of Kimia Farma is as follows:

Board of Directors:

• Djagad Prakasa Dwialam (President Director)
• Hanadi Setiarto
• Disril Revolin Putra
• Hadi Kardoko
• Jasmine Kamiasti Karsono
• Willy Meridian

Board of Commissioners:

• Stefan Looho (President Commissioner/Independent Commissioner)
• Diah Kusumawardani
• Fachmi Idris
• Suprianto
• Sumarjati Arjoso

Company Focuses on Strengthening Governance

The company stated that the decisions taken in the EGMS are part of its strategic efforts to strengthen governance and accelerate the implementation of the company’s restructuring program. Kimia Farma aims to become more responsive to developments in the national healthcare industry.

PHOTO: INFOBANKNEWS

This article was created with AI assistance.